How Celgene Added A New Drug To Its Wheelhouse A Month Early

Shares of Acceleron Pharma popped Friday after the biotech company gained Food and Drug Administration approval for a Celgene-partnered anemia treatment in patients with beta thalassemia.

The post How Celgene Added A New Drug To Its Wheelhouse A Month Early appeared first on Investor’s Business Daily.

Author: ALLISON GATLIN | Source

This article does not constitute investment advice. We are not affiliated or responsible for content hosted on 3rd-party sites in any way.

Click here for great deals & savings!